Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.36B | 11.40B | 10.60B | 10.54B | 10.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.36B | 11.40B | 10.60B | 10.54B | 10.35B |
| Cost of Revenue | 6.12B | 6.55B | 6.26B | 6.19B | 6.13B |
| Gross Profit | 4.25B | 4.84B | 4.34B | 4.35B | 4.22B |
| SG&A Expenses | 2.06B | 2.18B | 2.08B | 2.18B | 2.16B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 30.00M | -- | -- | -- |
| Total Operating Expenses | 8.52B | 9.13B | 8.68B | 8.71B | 8.62B |
| Operating Income | 1.84B | 2.26B | 1.91B | 1.83B | 1.73B |
| Income Before Tax | 1.61B | 1.97B | 1.73B | 1.68B | 1.61B |
| Income Tax Expenses | 95.00M | 150.00M | 99.00M | 128.00M | 281.00M |
| Earnings from Continuing Operations | 1.51B | 1.82B | 1.63B | 1.55B | 1.33B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | 6.00M | -- | -6.00M | -4.00M |
| Net Income | 1.51B | 1.83B | 1.63B | 1.55B | 1.33B |
| EBIT | 1.84B | 2.26B | 1.91B | 1.83B | 1.73B |
| EBITDA | 2.55B | 3.01B | 2.65B | 2.63B | 2.56B |
| EPS Basic | 3.99 | 4.79 | 4.27 | 4.05 | 3.48 |
| Normalized Basic EPS | 2.85 | 3.62 | 2.96 | 2.76 | 2.71 |
| EPS Diluted | 3.98 | 4.78 | 4.25 | 4.04 | 3.46 |
| Normalized Diluted EPS | 2.84 | 3.61 | 2.94 | 2.75 | 2.70 |
| Average Basic Shares Outstanding | 378.00M | 382.00M | 382.00M | 382.00M | 382.00M |
| Average Diluted Shares Outstanding | 379.00M | 383.00M | 384.00M | 383.00M | 384.00M |
| Dividend Per Share | 0.43 | 0.39 | 0.39 | 0.39 | 0.39 |
| Payout Ratio | 9.89% | 8.14% | 9.20% | 9.63% | 10.17% |